William Hildebrand to Adult
                            
                            
                                This is a "connection" page, showing publications William Hildebrand has written about Adult.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.159
         
        
        
     
 
    
        
        - 
            Profiling antibodies to class II HLA in transplant patient sera. Hum Immunol. 2014 Mar; 75(3):261-70.
            
            
                Score: 0.046
             
- 
            Identification of class I HLA T cell control epitopes for West Nile virus. PLoS One. 2013; 8(6):e66298.
            
            
                Score: 0.044
             
- 
            Determinants governing T cell receptor a/ß-chain pairing in repertoire formation of identical twins. Proc Natl Acad Sci U S A. 2020 01 07; 117(1):532-540.
            
            
                Score: 0.017
             
- 
            Urinary Peptides As a Novel Source of T Cell Allergen Epitopes. Front Immunol. 2018; 9:886.
            
            
                Score: 0.015
             
- 
            T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells. PLoS One. 2017; 12(11):e0188288.
            
            
                Score: 0.015
             
- 
            A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais. PLoS One. 2011; 6(8):e23603.
            
            
                Score: 0.010
             
- 
            HLA alleles and haplotypes among the Lakota Sioux: report of the ASHI minority workshops, part III. Hum Immunol. 2004 Jan; 65(1):78-89.
            
            
                Score: 0.006
             
- 
            Heterozygosity or homozygosity for 2 HLA class II haplotypes predict favorable outcomes for renal cell carcinoma treated with cytokine therapy. J Urol. 2003 Jun; 169(6):2084-8.
            
            
                Score: 0.006